4 latest FDA approvals

Here are the four latest drugs or medical devices approved by the Food and Drug Administration this week.

1. Lucentis is the first FDA-approved treatment for diabetic retinopathy patients with or without diabetic macular edema.

2. Tecentriq can now be used to treat patients with advanced bladder cancer who are not eligible for standard chemotherapy.

3. Cardea Solo is a wearable electrocardiogram sensor used to diagnose heart arrhythmias.

4. GammaCore is a handheld device used to treat cluster headaches.

More articles on supply chain:

Global pharmerging market to reach $1.4B by 2025
Price hikes likely added $8.7B to pharma's net income for 2016, report finds
ASCO: Strategies to control drug costs hinder cancer patient care

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.